MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-Catenin SignalingPingyu Zhang, Dina Lev, Aviad Hoffman et al.|Cancer Research|2012Cited by 111
Localized and metastatic myxoid/round cell liposarcomaAviad Hoffman, Raphael E. Pollock, Chad J. Creighton et al.|Cancer|2013Cited by 107
Diagnosis, Management, and Outcome of Patients with Dedifferentiated Liposarcoma Systemic MetastasisMarkus P. Ghadimi, Dina Lev, Aviad Hoffman et al.|Annals of Surgical Oncology|2011Cited by 70